Comparative Analysis of Ethical-the-counter Drugs and Over-the-counter Drugs for the Adverse Events from the Community Pharmacy |
Lee, Mo-Se
(Regional pharmacovigilance center, The Korea Pharmaceutical Association)
Park, So-Hee (School of pharmacy, Sungkyunkwan University) Kim, Na-Young (Regional pharmacovigilance center, The Korea Pharmaceutical Association) Oh, In-Sun (School of pharmacy, Sungkyunkwan University) Lee, Jung-Min (Regional pharmacovigilance center, The Korea Pharmaceutical Association) Lee, Eui-kyung (School of pharmacy, Sungkyunkwan University) Shin, Ju-Young (School of pharmacy, Sungkyunkwan University) |
1 | Korea Institute of Drug Safety and Risk Management. Pharmacovigilance terms. Available from https://www.drugsafe.or.kr/iwt/ds/ko/information/EgovDrugWatchTerm.do. Accessed April 18, 2018. |
2 | Yu YM, Choi SA, Lee MS, et al. The clinical characteristics of adverse drug reactions reported from the community pharmacy. Korean J Clin Pharm 2014;24. |
3 | Sultana J, Cutroneo P, Trifiro G. Clinical and economic burden of adverse drug reactions. J Pharmacol Pharmacother 2013;4(Suppl1): S73. DOI |
4 | Chan SL, Ang X, Sani LL, et al. Prevalence and characteristics of adverse drug reactions at admission to hospital: a prospective observational study. Br J Clin Pharmacol 2016;82(6):1636-46. DOI |
5 | Rodriguez-Monguio R, Otero MJ, Rovira J. Assessing the economic impact of adverse drug effects. Pharmacoeconomics 2003;21(9):623- 50. DOI |
6 | Taché SV, Sönnichsen A, Ashcroft DM. Prevalence of adverse drug events in ambulatory care: a systematic review. Ann Pharmacother 2011;45(7-8):977-89. DOI |
7 | Korean Statistical Information Service. Results of medical care benefits by type of medical care institutions and medical type (Total). Available from http://kosis.kr/statHtml/statHtml.do?orgId=350&tblId=TX_35001_A037. Accessed March 7, 2018. |
8 | Ministry of Food and Drug Safety. Regulation on standard of medicines category: Notification No.2015-81, article 2 Enforcement November 11, 2015. |
9 | Korean Statistical Information Service. Outpatients prescription number by prescription day and type of medical care institutions. Available from http://kosis.kr/statHtml/statHtml.do?orgId=354&tblId=DT_LEE_28. Accessed March 7, 2018. |
10 | Korea Institute of Drug Safety and Risk Management. 2017 Trends in safety information reporting pharmaceuticals. Available from http://open.drugsafe.or.kr/trend/trend/Read.jsp?ntt_id=2081. Accessed April 12, 2018. |
11 | Korea Institute of Drug Safety & Risk Management. Adverse Drug Reaction Assessment Report, 1st ed. Korea: Korea Institute of Drug Safety & Risk Management 2013;60-3. |
12 | Korean Statistical Information Service. OTC drugs regestration status. Available from http://kosis.kr/statHtml/statHtml.do?orgId=354&tblId=DT_354004N_007. Accessed March 23, 2018. |
13 | Lim KH, Shin HT, Sohn HS, et al. Comparison of WHO-ART Versus MedDRA, Internationally Standardized Terminology of adverse Drug Reaction Classification. Korean J Clin Pharm 2007;17(1):46-52. |
14 | WHO collaboration Centre for Drug Statistics Methodology. ATC Structure and principls. Available from https://www.whocc.no/atc/structure_and_principles/. Accessed March 28, 2018. |
15 | Uppsala Monitoring Centre. The use of the WHO-UMC system for standardised case causality assessment. Available from http://www.who-umc.org. Accessed June 11, 2018. |
16 | Korean Statistical Information Service. ETC/OTC drugs claim status. Available from http://kosis.kr/statHtml/statHtml.do?orgId=354& tblId=DT_354004N_020. Accessed November 21, 2017. |
17 | Rademaker M. Do women have more adverse drug reactions? Am J Clin Dermatol 2001;2(6):349-51. DOI |
18 | Gavaza P, Brown CM, Lawson KA, et al. Influence of attitudes on pharmacists' intention to report serious adverse drug events to the Food and Drug Administration. Br J Clin Pharmacol 2011; 72(1): 143-52. DOI |
19 | Rew SY, Koh YI, Shin HY, et al. Reporting and clinical features of adverse drug reactions from a single university hospital. Korean J Asthma Allergy Clin Immunol 2011;31(3):184-91. |
20 | Kim MG, Kang HR, Kim JH, et al. Analysis of adverse drug reactions collected by an electronic reporting system in a single hospital. Korean J Med 2009;77(5):601-9. |
21 | Chung EH. Clinical implication of adverse drug reaction surveillance in children. Allergy Asthma Respir Dis 2016;4(5):309-10. DOI |
22 | Cosentino M, Leoni O, Oria C, et al. Hospital-based survey of doctors' attitudes to adverse drug reactions and perception of drug-related risk for adverse reaction occurrence. Pharmacoepidemiol Drug Saf 1999; 8(Suppl 1): S27-35. DOI |
23 | Kim H. Attitude and knowlege of community pharmacists to adverse drug reaction reporting. Korean J Clin Pharm 2009;19(2): 159-66. |
24 | Health Insurance Review and Assessment Service. Frequent disease statistics. Available from http://opendata.hira.or.kr/op/opc/olapHifrqSickInfo.do. Accessed March 28, 2018. |
25 | Lee JK. Factors associated with drug misuse behaviors among polypharmacy elderly. Korean J Adult Nurs 2011;23(6):554-63. |
26 | Choi YH, Sohn UD. The surveillance of adverse drug reaction(ADR) reported. Korean J Clin Pharm 2003;13(2):72-81. |
27 | Sriram S, Ghasemi A, Ramasamy R, et al. Prevalence of adverse drug reactions at a private tertiary care hospital in south India. J Res Med Sci 2011;16(1):16. |